Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health, Inc. (NYSE: TDOC) is described as the global leader in virtual care, and the news surrounding the company reflects its focus on virtual urgent care, integrated care programs and financial performance. Company news includes announcements about enhancements to its 24/7 Care service, participation in major healthcare investor conferences, quarterly earnings results and leadership changes.
Recent updates highlight Teladoc Health’s work to expand its flagship 24/7 Care virtual urgent care service. The company has announced new capabilities that allow licensed care providers to treat a broader range of conditions, consult with board-certified specialists during visits, support preventive care using integrated claims and Health Information Exchange data, connect members to additional Teladoc Health programs and in-network providers, and check prescription benefits in real time through its Prism care delivery platform.
Investors and analysts can also find earnings-related news, including quarterly financial results for the Integrated Care and BetterHelp segments, revenue by type and geography, and non-GAAP measures such as adjusted EBITDA. Teladoc Health regularly issues press releases about its financial outlook, cash flow, and capital structure decisions, including the establishment of a senior secured revolving credit facility.
Other news items cover corporate governance and leadership developments, such as executive transitions and Board changes, as well as Teladoc Health’s participation in industry conferences and collaborations with other virtual care technology providers. This news page aggregates these updates so readers can follow Teladoc Health’s operational, strategic and financial developments over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Teladoc Health (TDOC) reported first quarter 2023 revenue of $629.2 million, reflecting an 11% year-over-year growth. However, the company posted a net loss of $69.2 million or ($0.42) per share, compared to a substantial loss of $6.67 billion in Q1 2022, which was mainly due to a prior goodwill impairment. Adjusted EBITDA decreased by 3% to $52.8 million. The Integrated Care segment saw revenue growth of 5% to $350 million, while BetterHelp revenue surged 21% to $279.3 million. Looking ahead, Teladoc projects Q2 2023 revenue of $635 - $660 million and expects a full year 2023 revenue between $2.575 - $2.675 billion. The financial outlook indicates potential improvement despite ongoing losses.
Teladoc Health is expanding its Provider-Based Care to include weight management and prediabetes programs, addressing a significant health issue in the U.S., where 42% of adults are estimated to live with obesity and 1 in 3 have prediabetes. This initiative builds on its existing diabetes and hypertension solutions, offering personalized care plans and coaching through digital tools. The new service aims to optimize medications like GLP-1 agonists and SGLT2 inhibitors, ensuring comprehensive support for individuals managing cardiometabolic health risks. Launching in Q3 2023, the expansion exemplifies Teladoc's commitment to improving health outcomes through innovative, evidence-based solutions.